Questions that need answers: research needs to keep pace with escalating cannabis issues

The changing and evolving landscape of cannabis use has intensified the need for answers and has raised new questions.

One of the pharmacology questions left to be answered is about the use of CDB, writes Ruth Ross who says that while there is good data on the use of CBD as a medicine for epilepsy in children, these trials and others have highlighted potential effects of CBD on the liver and in modifying the levels of other medications that patients may be taking. Pexels photograph by Elsa Olofsson, cbdoracle.com

Opinion

BY RUTH ROSS

October 28, 2020

As a seasoned researcher in the field of cannabis and cannabinoid pharmacology, there are a few key areas where the current lack of information and knowledge gaps raise concerns. Some of these gaps in knowledge have been the topic of research for decades, while others have emerged much more recently...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy